Janus Henderson Group’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-29,470
| Closed | -$32K | – | 2581 |
|
|
2023
Q3 | $32K | Buy |
29,470
+335
| +1% | +$364 | ﹤0.01% | 2555 |
|
|
2023
Q2 | $66.9K | Buy |
29,135
+505
| +2% | +$1.16K | ﹤0.01% | 2582 |
|
|
2023
Q1 | $69.4K | Buy |
28,630
+17,269
| +152% | +$41.9K | ﹤0.01% | 2642 |
|
|
2022
Q4 | $21.6K | Sell |
11,361
-11,361
| -50% | -$21.6K | ﹤0.01% | 2452 |
|
|
2022
Q3 | $54K | Buy |
22,722
+11,361
| +100% | +$27K | ﹤0.01% | 2517 |
|
|
2022
Q2 | $21K | Sell |
11,361
-454
| -4% | -$839 | ﹤0.01% | 2587 |
|
|
2022
Q1 | $25K | Buy |
11,815
+29
| +0.2% | +$61 | ﹤0.01% | 2633 |
|
|
2021
Q4 | $46K | Buy |
+11,786
| New | +$46K | ﹤0.01% | 2541 |
|